Pages that link to "Q42039847"

The following pages link to Effects of 5-hydroxytryptamine 3 receptor antagonists on gastrointestinal motor activity in conscious dogs (Q42039847):

Displaying 14 items.

• 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake (Q24538184) (← links)
• Interdigestive migrating motor complex -its mechanism and clinical importance (Q28817940) (← links)
• Mechanism of interdigestive migrating motor complex (Q30465489) (← links)
• Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome (Q34728081) (← links)
• The hungry stomach: physiology, disease, and drug development opportunities. (Q35215647) (← links)
• Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic (Q36711574) (← links)
• Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs (Q37241590) (← links)
• Emesis in dogs: a review (Q37688293) (← links)
• Mechanism of interdigestive migrating motor complex in conscious dogs (Q43208375) (← links)
• Intragastric administration of rikkunshito stimulates upper gastrointestinal motility and gastric emptying in conscious dogs. (Q47824323) (← links)
• Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors (Q48146857) (← links)
• Effect of nitric oxide synthase inhibition on plasma motilin release in fasted dogs (Q48742472) (← links)
• Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs (Q60701664) (← links)
• Effects of motilin and mitemcinal (GM-611) on gastrointestinal contractile activity in rhesus monkeys in vivo and in vitro (Q80152563) (← links)